-
Thematic Analysis
NewStrategic Partnerships in Fintech – Thematic Intelligence
Strategic Partnerships in Fintech Thematic Report Overview Strategic partnerships for fintech companies can include traditional vendor relationships, new niche fintech partners, big tech partners, and/or bank-as-a-service of distribution arrangements with firms outside of financial services. The right partnership can deliver overnight scale via access to new markets or customers or neutralize a disintermediating threat.Moreover, working with proven partners and business models for distribution or as a tech partner will be more attractive. The ‘strategic partnerships in fintech’ thematic intelligence report...
-
Product Insights
NewLikelihood of Approval Analysis for Malignant Pleural Effusion
Overview How likely is it that the drugs in Malignant Pleural Effusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Pleural Effusion Overview Malignant pleural effusion is a condition in...
-
Product Insights
NewLikelihood of Approval Analysis for Endometriosis
Overview How likely is it that the drugs in Endometriosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Endometriosis Overview Endometriosis is an often painful disorder in which tissue that normally...
-
Product Insights
NewLikelihood of Approval Analysis for Community Acquired Pneumonia
Overview How likely is it that the drugs in Community Acquired Pneumonia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Community Acquired Pneumonia Overview Community-acquired pneumonia (CAP) is defined as pneumonia...
-
Product Insights
NewLikelihood of Approval Analysis for Ebolavirus Infections (Ebola Hemorrhagic Fever)
Overview How likely is it that the drugs in Ebolavirus Infections (Ebola Hemorrhagic Fever) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ebolavirus Infections (Ebola Hemorrhagic Fever) Overview Ebola is a...
-
Product Insights
NewLikelihood of Approval Analysis for Cholestasis
Overview How likely is it that the drugs in Cholestasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cholestasis Overview Cholestasis is the slowing or stalling of bile flow from liver....
-
Product Insights
NewLikelihood of Approval Analysis for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Overview How likely is it that the drugs in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Arterial Disease (PAD)/ Peripheral Vascular...
-
Product Insights
NewLikelihood of Approval Analysis for Marginal Zone B-cell Lymphoma
Overview How likely is it that the drugs in Marginal Zone B-cell Lymphoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Marginal Zone B-cell Lymphoma Overview Marginal zone B-cell lymphoma is...
-
Product Insights
NewLikelihood of Approval Analysis for Paraganglioma (Glomus Jugulare Tumor)
Overview How likely is it that the drugs in Paraganglioma (Glomus Jugulare Tumor) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paraganglioma (Glomus Jugulare Tumor) Overview Abnormal growth of chromaffin cells,...